Fiduciary Group’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.91M | Sell |
103,574
-16,936
| -14% | -$451K | 0.25% | 86 |
|
|
2025
Q4 | $3M | Sell |
120,510
-12,316
| -9% | -$311K | 0.25% | 81 |
|
|
2025
Q3 | $3.38M | Sell |
132,826
-3,547
| -3% | -$87.5K | 0.3% | 80 |
|
|
2025
Q2 | $3.31M | Buy |
136,373
+11,658
| +9% | +$272K | 0.31% | 81 |
|
|
2025
Q1 | $3.16M | Buy |
124,715
+7,046
| +6% | +$184K | 0.32% | 78 |
|
|
2024
Q4 | $3.12M | Buy |
117,669
+31,479
| +37% | +$854K | 0.31% | 79 |
|
|
2024
Q3 | $2.49M | Sell |
86,190
-7,426
| -8% | -$217K | 0.25% | 91 |
|
|
2024
Q2 | $2.62M | Sell |
93,616
-7,466
| -7% | -$206K | 0.28% | 80 |
|
|
2024
Q1 | $2.81M | Sell |
101,082
-4,840
| -5% | -$134K | 0.31% | 79 |
|
|
2023
Q4 | $3.05M | Sell |
105,922
-110,301
| -51% | -$3.33M | 0.36% | 70 |
|
|
2023
Q3 | $7.17M | Sell |
216,223
-17,634
| -8% | -$624K | 0.92% | 33 |
|
|
2023
Q2 | $8.58M | Sell |
233,857
-7,648
| -3% | -$298K | 1.05% | 27 |
|
|
2023
Q1 | $9.85M | Sell |
241,505
-7,603
| -3% | -$328K | 1.28% | 20 |
|
|
2022
Q4 | $12.8M | Sell |
249,108
-6,969
| -3% | -$334K | 1.7% | 13 |
|
|
2022
Q3 | $12.1M | Sell |
256,077
-726
| -0.3% | -$35.3K | 1.57% | 16 |
|
|
2022
Q2 | $12.4M | Sell |
256,803
-3,378
| -1% | -$172K | 1.55% | 18 |
|
|
2022
Q1 | $12.9M | Buy |
260,181
+6,814
| +3% | +$354K | 1.7% | 15 |
|
|
2021
Q4 | $15M | Sell |
253,367
-1,107
| -0.4% | -$54.8K | 1.66% | 16 |
|
|
2021
Q3 | $11.1M | Buy |
254,474
+1,459
| +0.6% | +$64.6K | 1.26% | 22 |
|
|
2021
Q2 | $11.4M | Buy |
253,015
+1,383
| +0.5% | +$53.8K | 1.32% | 22 |
|
|
2021
Q1 | $9.73M | Buy |
251,632
+2,938
| +1% | +$104K | 1.18% | 24 |
|
|
2020
Q4 | $8.56M | Sell |
248,694
-8,301
| -3% | -$304K | 1.13% | 26 |
|
|
2020
Q3 | $8.95M | Sell |
256,995
-1,020
| -0.4% | -$35.8K | 1.35% | 22 |
|
|
2020
Q2 | $8.01M | Buy |
258,015
+5,072
| +2% | +$172K | 1.34% | 22 |
|
|
2020
Q1 | $7.83M | Buy |
252,943
+14,386
| +6% | +$490K | 1.54% | 20 |
|
|
2019
Q4 | $8.87M | Buy |
238,557
+20,239
| +9% | +$721K | 1.41% | 20 |
|
|
2019
Q3 | $7.44M | Buy |
218,318
+10,986
| +5% | +$399K | 1.3% | 22 |
|
|
2019
Q2 | $8.52M | Buy |
207,332
+6,009
| +3% | +$239K | 1.53% | 19 |
|
|
2019
Q1 | $8.11M | Buy |
201,323
+2,197
| +1% | +$88K | 1.51% | 20 |
|
|
2018
Q4 | $8.25M | Buy |
199,126
+6,623
| +3% | +$275K | 1.7% | 16 |
|
|
2018
Q3 | $8.05M | Buy |
192,503
+1,543
| +0.8% | +$59.4K | 1.58% | 18 |
|
|
2018
Q2 | $6.57M | Buy |
190,960
+340
| +0.2% | +$11.6K | 1.39% | 21 |
|
|
2018
Q1 | $6.42M | Buy |
190,620
+9,201
| +5% | +$316K | 1.39% | 22 |
|
|
2017
Q4 | $6.23M | Sell |
181,419
-2,563
| -1% | -$87.4K | 1.33% | 24 |
|
|
2017
Q3 | $6.23M | Buy |
183,982
+6,306
| +4% | +$203K | 1.4% | 20 |
|
|
2017
Q2 | $5.66M | Buy |
177,676
+3,924
| +2% | +$124K | 1.31% | 25 |
|
|
2017
Q1 | $5.64M | Buy |
173,752
+22,998
| +15% | +$725K | 1.34% | 23 |
|
|
2016
Q4 | $4.65M | Buy |
150,754
+5,134
| +4% | +$157K | 1.2% | 27 |
|
|
2016
Q3 | $4.68M | Buy |
145,620
+613
| +0.4% | +$20.5K | 1.27% | 24 |
|
|
2016
Q2 | $4.84M | Sell |
145,007
-2,987
| -2% | -$95.3K | 1.35% | 22 |
|
|
2016
Q1 | $4.16M | Sell |
147,994
-3,554
| -2% | -$102K | 1.21% | 27 |
|
|
2015
Q4 | $4.64M | Buy |
151,548
+6,369
| +4% | +$200K | 1.38% | 23 |
|
|
2015
Q3 | $4.33M | Buy |
145,179
+9,200
| +7% | +$295K | 1.44% | 16 |
|
|
2015
Q2 | $4.33M | Buy |
+135,979
| New | +$4.43M | 1.36% | 20 |
|
Other funds holding PFE
VCM
VPM
Fiduciary Group's PFE Position: Q1 2026 in Review
Fiduciary Group reduced its Pfizer (PFE) stake by 14% in Q1 2026, selling an estimated $451K and leaving 103,574 shares worth $2.91M. The position accounts for 0.25% of the portfolio, ranked #86.
Fiduciary Group first reported a position in PFE in Q2 2015 and has held it in 44 quarters since. The position peaked at $15M in Q4 2021. 2,937 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- Fiduciary Group held 103,574 shares of Pfizer worth $2.91M as of Q1 2026.
- Fiduciary Group sold 16,936 Pfizer shares in Q1 2026, an estimated $451K.
- Pfizer made up 0.25% of Fiduciary Group's portfolio in Q1 2026, its #86 holding.
- Fiduciary Group first reported a position in Pfizer in Q2 2015 and has held it in 44 quarters since.
- Fiduciary Group's Pfizer position peaked at $15M in Q4 2021.
- 2,937 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on Fiduciary Group's 13F filing for Q1 2026, filed 11 May 2026.